Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

REGN Regeneron Pharmaceuticals Inc

-21.52 (-2.18%)
After Hours
Last Updated: 17:04:19
Delayed by 15 minutes


Draw Mode:

Volume 792,163
Bid Price 967.00
Ask Price 969.90
News -
Day High 990.30


52 Week Range


Day Low 965.16
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-21.52 -2.18% 966.09 17:04:19
Open Price Low Price High Price Close Price Prev Close
989.91 965.16 990.30 966.09 987.61
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
22,932 792,163 $ 976.03 $ 773,173,047 - 684.805 - 998.325
Last Trade Time Type Quantity Stock Price Currency
17:26:52 3 $ 967.10 USD

Regeneron Pharmaceuticals (REGN) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Regeneron Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
106.04B 109.76M - 13.12B 3.95B 36.02 26.82
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Regeneron Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No REGN Message Board. Create One! See More Posts on REGN Message Board See More Message Board Posts

Historical REGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week953.57998.325947.8525982.42509,19212.521.31%
1 Month945.61998.325923.0333955.86499,44020.482.17%
3 Months840.00998.325831.19913.47574,098126.0915.01%
6 Months833.37998.325769.19865.89501,416132.7215.93%
1 Year756.45998.325684.805810.68552,416209.6427.71%
3 Years455.63998.325441.00675.37672,110510.46112.03%
5 Years430.19998.325271.37570.81781,778535.90124.57%

Regeneron Pharmaceuticals Description

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.

Your Recent History

Delayed Upgrade Clock